Publication: Oral fluoroquinolones for maintenance treatment of melioidosis
2
item.page.dc.date.issued
1997-01-01
item.page.dc.type
item.page.dc.identifier.issn
00359203
item.page.dc.identifier.doi
item.page.dc.identifier.other
2-s2.0-0030664849
item.page.dc.rights
Mahidol University
item.page.dc.rights.holder
SCOPUS
item.page.dc.identifier.citation
Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.91, No.5 (1997), 599-601
punsarn.item.page.citation
W. Chaowagul, Y. Suputtamongkul, M. D. Smith, N. J. White Oral fluoroquinolones for maintenance treatment of melioidosis. Transactions of the Royal Society of Tropical Medicine and Hygiene. Vol.91, No.5 (1997), 599-601. doi:10.1016/S0035-9203(97)90044-4 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/17997
Research Projects
Organizational Units
Authors
Journal Issue
relationships.isThesisOf
item.page.dc.title
Oral fluoroquinolones for maintenance treatment of melioidosis
item.page.dc.contributor.author
item.page.dc.contributor.other
item.page.dc.description.abstract
Ciprofloxacin (20 mg/kg/d) or ofloxacin (12 mg/kg/d) given for a median of 15 weeks (range 12-40) were used for maintenance treatment of 57 adult patients with melioidosis. The median duration of follow-up in the 45 patients who complied with treatment and were followed for at least 6 months was 28 months (range 6-65). Fluoroquinolone treatment was well tolerated. There were 13 treatment failures (5 failures to respond, 8 relapses), a failure rate of 29% (95% confidence interval 17-43%). The median time to treatment failure was 7 months (range 2-26). These results are inferior to those with courses lasting 20 weeks of amoxycillin/clavulanic acid or the combination of chloramphenicol, doxycycline and trimethoprim/sulphamethoxazole, and suggest that the fluoroquinolones should be reserved as third line agents, and not used for the maintenance treatment of melioidosis unless there is resistance to, or intolerance of, the other available antimicrobial compounds.
